Events

To help patients, caregivers, physicians, and other healthcare providers find COVID-19 treatment resources as quickly and easily as possible, the Reagan-Udall Foundation for the FDA today launched the online

The Reagan-Udall Foundation for the Food and Drug Administration has named

Molly Fogarty, Senior Vice President of Nestlé in the U.S., has been appointed to the Board of Directors for the Reagan-Udall Foundation for the Food and Drug Administration.

Nominations for the 2020 Innovations in Regulatory Science Awards are now open

The 2019 Innovations in Regulatory Science Awards Dinner honored Theresa M. Mullin, Phd; Compassionate Use Advisory Committee; and Cystic Fibrosis Foundation.

FDA’s Theresa Mullin, Compassionate Use Advisory Committee, and Cystic Fibrosis Foundation to be Honored with Innovations in Regulatory Science Awards  Honorees to be recognized on December 11 in Washington

The Reagan-Udall Foundation for the Food and Drug Administration has named Dr. Adrian F. Hernandez to its Board of Directors.

The Reagan-Udall Foundation for the FDA seeks nominations for key positions on its Steering Committee.

"Patients with cancer are treated with drugs already approved by the U.S. Food and Drug Administration (FDA) or with an investigational agent in a clinical trial.

The U.S. Food and Drug Administration (FDA) plans to provide oncologists with greater help in acquiring expanded access to investigational therapies.